Expression of c-FLIP in gastric cancer and its relation to tumor cell proliferation and apoptosis

Korean Journal of Internal Medicine

Volumn 22, Issue 4, 2007, Pages 263-269

  Ryang, Dae Yeul ^a   Joo, Young Eun ^a   Chung, Kyoung Myeun ^a   Lim, Sung Ryoun ^a   Jeong, Hye Kyong ^a   Kim, Hyung Il ^a   Lee, Wan Sik ^a   Park, Chang Hwan ^a   Kim, Hyun Soo ^a   Choi, Sung Kyu ^a   Rew, Jong Sun ^a   Lee, Jae Hyuk ^a   Park, Chang Soo ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Apoptosis; c FLIP; Cell proliferation; Stomach neoplasm

Indexed keywords

FLICE INHIBITORY PROTEIN; KI 67 ANTIGEN; CFLAR PROTEIN, HUMAN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NICK END LABELING; PROTEIN EXPRESSION; STOMACH CANCER; DISEASE COURSE; GENETICS; HEALTH SURVEY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PILOT STUDY; STOMACH TUMOR;

AGED; APOPTOSIS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; HEALTH STATUS INDICATORS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; PILOT PROJECTS; STOMACH NEOPLASMS;

EID: 43049101172     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2007.22.4.263     Document Type: Article

References (25)

1. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462, 1995
2. Barinaga M. Death by dozens of cuts. Science 280:32-34, 1998
3. Kiechle FL, Zhang X. Apoptosis: biochemical aspects and clinical implications. Clin Chim Acta 326:27-45, 2002
4. Salvesen GS, Dixit VM. Caspase activation: the induced-proximity model. Proc Natl Acad Sci U S A 96:10964-10967, 1999
5. Tschopp J, Irmler M, Thome M. Inhibition of fas death signals by FLIPs. Curr Opin Immunol 10:552-558, 1998
6. Yeh WC, Itie A, Elia AJ, Ng M, Shu HB, Wakeham A, Mirtsos C, Suzuki N, Bonnard M, Goeddel DV, Mak TW. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 12:633-642, 2000
7. Peter ME. The flip side of FLIP. Biochem J 382:e1-e3, 2004
8. Wajant H. Targeting the FLICE inhibitory protein (FLIP) in cancer therapy. Mol Interv 3:124-127, 2003
9. Chen HX, Liu YJ, Zhou XD, Luo RY. Expression of cellular FLICE/caspase-8 inhibitory protein is associated with malignant potential in endometrial carcinoma. Int J Gynecol Cancer 15:663-670, 2005
10. Zhou XD, Yu JP, Chen HX, Yu HG, Luo HS. Expression of cellular FLICE-inhibitory protein and its association with p53 mutation in colon cancer. World J Gastroenterol 11:2482-2485, 2005
11. Korkolopoulou P, Goudopoulou A, Voutsinas G, Thomas-Tsagli E, Kapralos P, Patsouris E, Saetta AA. c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations. Urology 63:1198-1204, 2004
12. Lee SH, Kim HS, Kim SY, Lee YS, Park WS, Kim SH, Lee JY, Yoo NJ. Increased expression of FLIP, an inhibitor of Fas-mediated apoptosis, in stomach cancer. APMIS 111:309-314, 2003
13. Zhou XD, Yu JP, Liu J, Luo HS, Chen HX, Yu HG. Overexpression of cellular FLICE-inhibitory protein (FLIP) in gastric adenocarcinoma. Clin Sci 106:397-405, 2004
14. McCormick D, Chong H, Hobbs C, Datta C, Hall PA. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1. Histopathology 22:355-360, 1993
15. Weidner N, Moore DH 2nd, Vartanian R. Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel "paraffin"-reactive MIB1 antibody. Hum Pathol 25:337-342, 1994
16. Chan AO, Luk JM, Hui WM, Lam SK. Molecular biology of gastric carcinoma: from laboratory to bedside. J Gastroenterol Hepatol 14:1150-1160, 1999
17. Lauren P. The two histologic main types of gastric carcinoma. Acta Pathol Microbiol Scand 64:31-49, 1965
18. Watanabe H, Jass JR, Sobin LH. Histologic typing of oesophageal and gastric Tumors. In: WHO International Histologic Classification of Tumors. Berlin, Heidelberg, New York, Paris, Tokyo, Hong Kong, Springer-Verlag, 1990
19. American Joint Committee on Cancer. Manual for staging cancer. In: Stomach cancer. p. 71-76, Philadelphia, Lippincott-Raven, 1997
20. Reed JA, Manahan LJ, Park CS, Brigati DJ. Complete one-hour immunohistochemistry based on capillary action. Biotechniques 13:434-443, 1992
21. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501, 1992
22. Wyllie AH, Morris RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 142:67-77, 1984
23. L is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J 21:3704-3714, 2002
24. Micheau O, Thome M, Schneider P, Holler N, Tschopp J, Nicholson DW, Briand C, Grutter MG. The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J Biol Chem 277:45162-45171, 2002
25. Boatright KM, Deis C, Denault JB, Sutherlin DP, Salvesen GS. Activation of caspases-8 and -10 by c-FLIPL. Biochem J 382:651-657, 2004